Chung-Han Lee, MD on KEYNOTE-146: Phase II Trial of LEN plus PEMBRO in mccRCC @sloan_kettering #ASCO2020 @ChungHanLee3 #ASCO

Chung-Han Lee, MD on KEYNOTE-146: Phase II Trial of LEN plus PEMBRO in mccRCC @sloan_kettering #ASCO2020 @ChungHanLee3 #ASCO

User Photo
Cancer-News

3 months
446 Views
Share
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:

Chung-Han Lee, MD @ChungHanLee3 of Memorial Sloan Kettering Cancer Center @sloan_kettering discusses the KEYNOTE-146/Study 111: Phase II trial of lenvatinib plus pembrolizumab for disease progression after PD-1/PD-L1 immune checkpoint inhibitor in metastatic clear cell renal cell carcinoma (mccRCC).

Read here: https://meetinglibrary.asco.org/record/186053/abstract

Up Next Autoplay
>